Gerstmann-Sträussler-Scheinker disease due to a novel prion protein gene mutation
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Prion diseases are rapidly progressive, fatal brain disorders arising sporadically, genetically, or by infection.1 Dominant, high-penetrance mutations in the gene (PRNP) encoding the prion protein (PrP) cause 5%–15% of human cases.2 Gerstmann-Sträussler-Scheinker (GSS) disease is an exceedingly rare inherited phenotype,2 defined neuropathologically by multicentric, PrP-containing amyloid plaques. We present a patient with prominent seizures, cognitive decline, and ataxia who was found to have a novel mutation in PRNP.
Case report.
A 34-year-old man presented in status epilepticus. Despite multiple anticonvulsants, he continued to have complex partial and generalized tonic-clonic seizures. He developed an unsteady gait, slurred speech, and personality change marked by disinhibition. Three years prior, he had onset of gradual cognitive decline, which accelerated following the onset of epilepsy. Eight years prior, the patient had developed night terrors, which resolved spontaneously after 6 years. Otherwise, the patient was healthy. His 7-year-old son was recently diagnosed with Asperger syndrome.
Examination showed a Montreal Cognitive Assessment score of 15/30. Neuropsychiatric assessment revealed memory and executive function deficits. The patient demonstrated saccadic pursuit, square wave jerks, and flaccid dysarthria. Power and reflexes were normal; plantar responses were flexor. There was diffuse paratonia and axial rigidity. Finger-to-nose testing was normal but he had mild difficulty with heel-to-shin testing. Rapid alternating movements were impaired by apraxia. Gait was slightly wide-based. Nonstimulus-sensitive myoclonus was present.
The patient underwent extensive investigations (table e-1 on the Neurology® Web site at www.neurology.org). Brain MRI on multiple occasions showed mild diffuse cortical atrophy and mild cerebellar vermian atrophy without restricted diffusion or gadolinium …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Differences in Age-related Retinal and Cortical Atrophy Rates in Multiple Sclerosis
Prof. Massimo Filippi and Dr. Paolo Preziosa
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Articles
A novel PRNP-P105S mutation associated with atypical prion disease and a rare PrPSc conformationE. Tunnell, R. Wollman, S. Mallik et al.Neurology, October 27, 2008 -
Articles
Inherited prion disease with 5-OPRIPhenotype modification by repeat length and codon 129S. Mead, T. E. F. Webb, T. A. Campbell et al.Neurology, August 20, 2007 -
Articles
Creutzfeldt–Jakob disease with a novel four extra-repeat insertional mutation in the PrP geneG. Rossi, G. Giaccone, L. Giampaolo et al.Neurology, August 08, 2000 -
Articles
High incidence of genetic human transmissible spongiform encephalopathies in ItalyA. Ladogana, M. Puopolo, A. Poleggi et al.Neurology, May 09, 2005